本页面由Tiger Trade Technology Pte. Ltd.提供服务

Monte Rosa Therapeutics

10.52
+0.22002.14%
盘后:10.520.00000.00%19:30 EDT
成交量:209.46万
成交额:2,187.40万
市值:8.97亿
市盈率:-6.03
高:10.63
开:10.29
低:10.14
收:10.30
52周最高:25.77
52周最低:8.53
股本:8,531.34万
流通股本:5,447.61万
量比:1.31
换手率:3.84%
股息:- -
股息率:- -
每股收益(TTM):-1.7450
每股收益(LYR):-0.4650
净资产收益率:-42.66%
总资产收益率:-21.63%
市净率:1.84
市盈率(LYR):-22.62

数据加载中...

2024/05/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/10

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/17

重要事件披露

Form 8-K - Current report
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]